Views & Analysis | Perspectives on pharma industry issues

Oncology

pharmaphorum podcast Episode 282 at ESMO26: Dr Chuck Link, Syncromune

ESMO26: Lowering toxicity, extending lives, with Syncromune

As the ESMO26 Congress commences in Madrid, pharmaphorum invited Syncromune Executive Chairman Dr Chuck Link onto the podcast.

Oncology

Why precision biomarkers will change the future of breast ca...

Blood-based biomarkers can provide an earlier, dynamic view of what is happening inside a patient, creating an opportunity to detect changes sooner.

Sales & Marketing

Benefits of marketing with AI tools, upward trajectory graph

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Oncology

Sponsored

12 Questions with Julia Jakl

Learn more about Julia Jakl, VP and Business Unit Head, Oncology UK at GSK, in a new 12 Questions With.

Market Access

Sponsored

The pre-commercial case for connecting data before acquiring...

For EBPs, launch requires a data strategy that starts with agreement on the KPIs, and those depend on the therapeutic areas.

Articles

The future of social media and pharma: collaboration

In Siren Interactive’s second of five rare disease articles, Katie Mihelich takes a look at pharma and patients’ use of social media. It’s hard to believe that popular social media has been a part of our lives for almost a decade now. This increased connectivity has…

Articles

Tunnah’s musings: lessons from listening to patients

As February sees pharmaphorum focus on patients, Paul Tunnah muses on what common lessons have already emerged for pharma from past patient interviews. If you have been following pharmaphorum in February you have probably noticed that we are focussing this month on ‘patients’ as our discipline focus, alongside …

Articles

Pharma gets social: world’s top pharma on Facebook

Daniel Ghinn continues his series by looking at the Facebook social media strategies for the top 15 pharma companies. Among digital channels embraced or ignored by pharmaceutical companies, Facebook is associated with some of the most...

Sales & Marketing

Ending rational disengagement: Bridging the strategy-reality...

Organisations must secure strategic buy-in, embed platforms in existing workflows, and provide reps with actionable physician-ready hypotheses.

Sales & Marketing

Building a social presence inside regulatory guardrails

In the UK, promoting prescription-only medicines to the public is prohibited by law and by the ABPI Code - social media reactions and shares included.

Digital

Sponsored

Why AI transformation is really about people

Jeff Kaminski, global head of AI and data at Axtria and a former industry analyst, discusses culture, governance, and leadership challenges around AI.

Digital